About Scentian Bio:
Scentian Bio: is a company based in Auckland (New Zealand) founded in 2020 by Andrew Kralicek and Jonathan Good.. Scentian Bio: has raised $3.1 million across 3 funding rounds from investors including OurCrowd, Gates Foundation and Fonterra. Scentian Bio: offers products and services including Real-time Sensors and Insect Receptor Technology. Scentian Bio: operates in a competitive market with competitors including Noze, Canaery, Yesse Technologies, NanoScent and SmartNanotubes Technologies, among others.
- Headquarter Auckland, New Zealand
- Founders Andrew Kralicek, Jonathan Good
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Scentian Bio Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.1 M (USD)
in 3 rounds
-
Latest Funding Round
$2.1 M (USD), Seed
Sep 27, 2023
-
Investors
OurCrowd
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Scentian Bio:
Scentian Bio: offers a comprehensive portfolio of products and services, including Real-time Sensors and Insect Receptor Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Detects chemical signals for health and environmental monitoring applications
Utilizes insect receptors to interpret volatile compounds in real time
Funding Insights of Scentian Bio:
Scentian Bio: has successfully raised a total of $3.1M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $2.1 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $2.1M
-
First Round
First Round
(27 Jan 2021)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Seed - Scentian Bio: | Valuation | Finistere Ventures , Toyota Ventures | |
| Nov, 2022 | Amount | Grant - Scentian Bio: | Valuation |
investors |
|
| Jan, 2021 | Amount | Seed - Scentian Bio: | Valuation | Finistere Ventures , Fonterra |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Scentian Bio:
Scentian Bio: has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include OurCrowd, Gates Foundation and Fonterra. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital firm and infrastructure firm investing in multiple sectors
|
Founded Year | Domain | Location | |
|
PE fund focused on high growth companies of New Zealand
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Scentian Bio:
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Scentian Bio:
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Scentian Bio: Comparisons
Competitors of Scentian Bio:
Scentian Bio: operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Noze, Canaery, Yesse Technologies, NanoScent and SmartNanotubes Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of AI-based platform for air-borne disease detection
|
|
| domain | founded_year | HQ Location |
Nose-computer interfaces are developed to digitize the sense of smell.
|
|
| domain | founded_year | HQ Location |
Nanochip-based olfactory systems are developed for odor detection.
|
|
| domain | founded_year | HQ Location |
Provider of air and scent quality control solutions for cars and utilities
|
|
| domain | founded_year | HQ Location |
Manufacturer of smell detector chips for diverse applications and IoT solutions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Scentian Bio:
Frequently Asked Questions about Scentian Bio:
When was Scentian Bio: founded?
Scentian Bio: was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Scentian Bio: located?
Scentian Bio: is headquartered in Auckland, New Zealand.
Who is the current CEO of Scentian Bio:?
Jonathan Good is the current CEO of Scentian Bio:. They have also founded this company.
Is Scentian Bio: a funded company?
Scentian Bio: is a funded company, having raised a total of $3.1M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Jan 27, 2021.
What does Scentian Bio: do?
Scentian Bio was founded in 2020 in Auckland, New Zealand. Biosensor devices based on insect odorant receptors are developed for commercial applications in the medical and food industries. A machine learning-based biosensing platform is offered to detect volatile organic compounds, such as off-notes in food and beverages, fraud and adulterants in raw materials, while also enabling new product creation and providing objective assessments of flavors and fragrances.
Who are the top competitors of Scentian Bio:?
Scentian Bio:'s top competitors include Canaery, Noze and Yesse Technologies.
What products or services does Scentian Bio: offer?
Scentian Bio: offers Real-time Sensors and Insect Receptor Technology.
Who are Scentian Bio:'s investors?
Scentian Bio: has 9 investors. Key investors include OurCrowd, Gates Foundation, Fonterra, Sprout Agritech, and Callaghan Innovation.